Welcome to our dedicated page for Manulife Finl news (Ticker: MFC), a resource for investors and traders seeking the latest updates and insights on Manulife Finl stock.
Manulife Financial Corporation (MFC) delivers insurance, wealth management, and retirement solutions across Canada, Asia, and the United States through its John Hancock division. This news hub provides investors and professionals with timely updates on corporate developments directly affecting market positioning and strategic direction.
Key resources include earnings reports, product innovation announcements, and regulatory filings. Users gain access to verified information about leadership changes, partnership agreements, and sustainability initiatives – all essential for assessing MFC's performance in global financial markets.
Regular updates cover digital transformation progress including AI implementation in customer service, reinsurance transactions, and expansion strategies in Asian markets. Content is curated to help stakeholders monitor operational milestones and industry trends impacting this multinational insurer.
Bookmark this page for streamlined access to MFC's official communications and third-party analyses. Combine frequent checks with portfolio reviews to maintain informed decision-making in dynamic financial markets.
John Hancock and its parent company Manulife (NYSE: MFC) announced a five-year, multimillion-dollar research collaboration with MIT AgeLab to advance longevity innovation and research. This partnership aims to develop actionable insights for businesses, policymakers, and individuals, focusing on improving the quality of life for aging populations. The initiative will create a longevity preparedness index, measuring Americans' readiness for longer, healthier lives, with plans to expand to Canada. Additional workshops and industry consortium participation will further explore critical aspects of longevity.
Manulife Financial announced the election of 13 nominees as directors at the Annual Meeting of Shareholders. The detailed voting results showed overwhelming support for the nominees, with high percentages of votes in favor of each candidate. Anna Manning, a nominee for director, deferred her appointment due to personal circumstances but is expected to join the board in the next quarter.
Manulife's Board of Directors declared quarterly dividends for non-cumulative preferred shares of Manulife Financial The dividends will be payable to shareholders on or after June 19, 2024. The announcement includes the dividend amounts for various series of Class A and Class 1 Shares.
Manulife's Board of Directors declared a quarterly common shareholders' dividend of $0.40 per share on the common shares of Manulife, payable on and after June 19, 2024. The company will purchase common shares on the open market in connection with the reinvestment of dividends and optional cash purchases under its Canadian and U.S. Dividend Reinvestment and Share Purchase Plans.
Manulife Financial reported its first quarter 2024 results, showcasing strong core ROE and topline growth. The company closed the largest LTC reinsurance transaction in the industry. Key highlights include core earnings of $1.8 billion, up 16% from 1Q23, EPS of $0.45, down 38% from 1Q23, and APE sales up 21%.
Front Street Re, an international Insurtech and reinsurance company, appointed Edison Fong as Chief Executive Officer. Fong brings actuarial experience and financial acumen to drive innovation and efficiency. Lexasure Financial Group is committed to Front Street Re's growth, focusing on global partnerships and tailored products.
Manulife Financial has amended its normal course issuer bid (NCIB) to repurchase up to an additional 40 million of its common shares, now totaling 90 million shares. This decision aims to maintain healthy regulatory capital ratios, generate shareholder value, and mitigate the impact on diluted Earnings Per Share and core Earnings Per Share from reinsurance transactions. The NCIB will be in effect until February 22, 2025, allowing repurchases through various trading platforms. Manulife may also engage in private agreements, derivative-based programs, and other methods to acquire shares within regulatory limits. The company's current NCIB has already repurchased over 12 million common shares.